心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

ST段抬高型心肌梗死基层合理用药指南

2021-04-02 中华医学会临床药学分会 中华全科医师杂志

急性ST段抬高型心肌梗死

ST段抬高型心肌梗死是指急性心肌缺血性坏死,通常多为在冠状动脉不稳定斑块破裂、糜烂、侵蚀及内皮损伤基础上继发血栓形成而导致冠状动脉急性、持续、完全闭塞,血供急剧减少或中断。

中文标题：

ST段抬高型心肌梗死基层合理用药指南

发布机构：

中华医学会临床药学分会

发布日期：

2021-04-02

简要介绍：

ST段抬高型心肌梗死(ST-segment elevated myocardial infarction, STEMI)是指急性心肌缺血性坏死,通常多为在冠状动脉不稳定斑块破裂、糜烂、侵蚀及内皮损伤基础上继发血栓形成而导致冠状动脉急性、持续、完全闭塞,血供急剧减少或中断,从而使心肌细胞缺血、损伤及坏死的临床综合征。STEMI是冠心病的严重类型,为致死致残的主要原因。

下载附件：
点击下载

(因为版权问题，不支持下载)

评论区 (28)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2237481, encodeId=03c8223e48126, content=学习了，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcf28251136, createdName=ms7000000243722881, createdTime=Sun Nov 17 21:31:40 CST 2024, time=2024-11-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2195125, encodeId=1c5b219512533, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94526425916, createdName=ms9000000691468056, createdTime=Mon Mar 25 00:31:55 CST 2024, time=2024-03-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2192184, encodeId=6c2f219218478, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155510817, createdName=ms8000000533562841, createdTime=Sat Mar 09 04:12:29 CST 2024, time=2024-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099730, encodeId=baf12099e3053, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94778425046, createdName=ms1000002115396352, createdTime=Thu Nov 10 20:47:42 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224689, encodeId=20e41224689c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Mon Jun 06 10:25:48 CST 2022, time=2022-06-06, status=1, ipAttribution=)]
    2024-11-17 ms7000000243722881 来自江西省

    学习了，天天向上

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2237481, encodeId=03c8223e48126, content=学习了，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcf28251136, createdName=ms7000000243722881, createdTime=Sun Nov 17 21:31:40 CST 2024, time=2024-11-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2195125, encodeId=1c5b219512533, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94526425916, createdName=ms9000000691468056, createdTime=Mon Mar 25 00:31:55 CST 2024, time=2024-03-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2192184, encodeId=6c2f219218478, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155510817, createdName=ms8000000533562841, createdTime=Sat Mar 09 04:12:29 CST 2024, time=2024-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099730, encodeId=baf12099e3053, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94778425046, createdName=ms1000002115396352, createdTime=Thu Nov 10 20:47:42 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224689, encodeId=20e41224689c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Mon Jun 06 10:25:48 CST 2022, time=2022-06-06, status=1, ipAttribution=)]
    2024-03-25 ms9000000691468056 来自山西省

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2237481, encodeId=03c8223e48126, content=学习了，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcf28251136, createdName=ms7000000243722881, createdTime=Sun Nov 17 21:31:40 CST 2024, time=2024-11-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2195125, encodeId=1c5b219512533, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94526425916, createdName=ms9000000691468056, createdTime=Mon Mar 25 00:31:55 CST 2024, time=2024-03-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2192184, encodeId=6c2f219218478, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155510817, createdName=ms8000000533562841, createdTime=Sat Mar 09 04:12:29 CST 2024, time=2024-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099730, encodeId=baf12099e3053, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94778425046, createdName=ms1000002115396352, createdTime=Thu Nov 10 20:47:42 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224689, encodeId=20e41224689c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Mon Jun 06 10:25:48 CST 2022, time=2022-06-06, status=1, ipAttribution=)]
    2024-03-09 ms8000000533562841 来自江苏省

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2237481, encodeId=03c8223e48126, content=学习了，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcf28251136, createdName=ms7000000243722881, createdTime=Sun Nov 17 21:31:40 CST 2024, time=2024-11-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2195125, encodeId=1c5b219512533, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94526425916, createdName=ms9000000691468056, createdTime=Mon Mar 25 00:31:55 CST 2024, time=2024-03-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2192184, encodeId=6c2f219218478, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155510817, createdName=ms8000000533562841, createdTime=Sat Mar 09 04:12:29 CST 2024, time=2024-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099730, encodeId=baf12099e3053, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94778425046, createdName=ms1000002115396352, createdTime=Thu Nov 10 20:47:42 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224689, encodeId=20e41224689c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Mon Jun 06 10:25:48 CST 2022, time=2022-06-06, status=1, ipAttribution=)]
    2022-11-10 ms1000002115396352

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2237481, encodeId=03c8223e48126, content=学习了，天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bcf28251136, createdName=ms7000000243722881, createdTime=Sun Nov 17 21:31:40 CST 2024, time=2024-11-17, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2195125, encodeId=1c5b219512533, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94526425916, createdName=ms9000000691468056, createdTime=Mon Mar 25 00:31:55 CST 2024, time=2024-03-25, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2192184, encodeId=6c2f219218478, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=30155510817, createdName=ms8000000533562841, createdTime=Sat Mar 09 04:12:29 CST 2024, time=2024-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2099730, encodeId=baf12099e3053, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94778425046, createdName=ms1000002115396352, createdTime=Thu Nov 10 20:47:42 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224689, encodeId=20e41224689c6, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210923/798b9a11e1834c52b6667d71ec29a2fe/c4404e92055a461b85f5cf0c06bb8497.jpg, createdBy=06ab5182837, createdName=向阳花开, createdTime=Mon Jun 06 10:25:48 CST 2022, time=2022-06-06, status=1, ipAttribution=)]
    2022-06-06 向阳花开

    学习了

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

急性ST段抬高型心肌梗死诊断和治疗指南（2019）解读

暂未更新 · 2019-12-30

急性ST段抬高型心肌梗死溶栓治疗的合理用药指南（第2版）

国家卫生计生委合理用药专家委员会 · 2019-01-30

2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理

美国急诊医师学会(ACEP,American College of Emergency Physicians) · 2017-11-07

拓展阅读

2017 ACEP临床决策：需要进行再灌注治疗的急性ST段抬高型心肌梗死患者的急诊管理

美国急诊医师学会(ACEP,American College of Emergency Physicians) · 2017-11-07

急性ST段抬高型心肌梗死溶栓治疗的合理用药指南（第2版）

国家卫生计生委合理用药专家委员会 · 2019-01-30

急性ST段抬高型心肌梗死诊断和治疗指南（2019）解读

暂未更新 · 2019-12-30

中药通心络防治急性ST段抬高型心肌梗死心肌无再流中国专家共识（2022年）

国家中医药管理局重大疑难疾病(急性心肌梗死)中西医临床协作试点项目组 · 2022-07-18

急性ST段抬高型心肌梗死溶栓治疗专家共识

暂未更新 · 2024-07-27